Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

09/05/2025 07:37

May 9 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2025        Mar 31, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1.15                1.38             6.30     
                 (-16.5 pct)         (+18.0 pct)      (+0.1 pct)  
  Operating        44 mln              214 mln          215 mln   
                 (-79.5 pct)                          (-65.9 pct) 
  Recurring        11 mln              229 mln          200 mln   
                 (-95.1 pct)                          (-70.9 pct) 
  Net              292 mln             472 mln          300 mln   
                 (-38.1 pct)                          (-66.6 pct) 
  EPS             5.83 yen            9.41 yen         5.98 yen   
  Ann Div                                NIL                      
  -Q2 div                                NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T